Find a clinical trial

Search by keyword
Phases
Recruitment Status
Indications
Reset


A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines


Phase: Phase I/II Trial

Status: Not Yet recruiting

Indication: Moderate to Severe Upper Facial Lines

A Study to Assess the Safety and Efficacy of IPN10200 of in Adult Participants With Upper Limb Spasticity.


Phase: Phase I/II Trial

Status: Not Yet recruiting

Indication: Spasticity

An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in FOP Subjects in France


Phase: Phase II Trial

Status: Active, not recruiting

Indication: Fibrodysplasia Ossificans Progressiva

An Efficacy and Safety Study of Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva.


Phase: Phase III Trial

Status: Active, not recruiting

Indication: Fibrodysplasia Ossificans Progressiva

An Open-Label Extension Study of Palovarotene Treatment in FOP


Phase: Phase II Trial

Status: Active, not recruiting

Indication: Fibrodysplasia Ossificans Progressiva


The list above displays information about clinical trials sponsored by Ipsen.

Only interventional studies that are not yet recruiting, recruiting, active not recruiting or completed since 2015 will be displayed.

The study results will be available on clintrial.gov from 12 months after the end of the study.

To learn more about available studies, go on: https://clinicaltrials.gov/.

Last updated date: 04/22/2021


© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021